This performance aligns with what some analysts refer to as the "Generic Revival" theme, which is expected to be a significant driver of near-term growth for the company. Amneal's growth strategy ...

deep dives into generic leaders—such as Teva, Sandoz, and Viatris—and more. Download the report to learn how to leverage these top companies’ growth plans for your investing strategy.

Aetna recently filed a lawsuit against pharmaceutical manufacturers for allegedly conspiring to overcharge the insurer for ...